Novartis Pharmaceuticals announces a joint investment company with Qualcomm
|
13 January 2015 |
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
|
07 January 2015 |
Novartis Foundation symposium showcases sustainable healthcare interventions
|
21 November 2014 |
New data on the global economic impact and burden of preventable blindness and vision impairment
|
09 October 2014 |
Novartis announces clinical collaboration to evaluate Bristol-Myers Squibb's novel immunotherapy in combination treatments for NSCLC
|
06 October 2014 |
Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
|
02 September 2014 |
Novartis provides drug candidate compounds to TB Alliance
|
20 August 2014 |
Novartis maintained strong innovation momentum in second quarter
|
17 July 2014 |
Novartis to license Google "smart lens" technology
|
15 July 2014 |
Novartis reinforces its leadership in research with new global guidelines for Investigator Initiated Trials (IITs)
|
08 July 2014 |